Systemic Therapy for Patients with Advanced HER2 Positive Breast Cancer Guideline
ASCO Guidelines - Podcast tekijän mukaan American Society of Clinical Oncology (ASCO)
An interview with Dr. Nancy E. Davidson from Fred Hutchinson Cancer Research Center and University of Washington on the guideline update which provides recommendations on systemic therapy for patients with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines
